From
Brain Science to Full Vision

RevitalVision is used to improve vision in amblyopic adults as a standalone therapy and when patching is no longer effective! It is the FDA approved treatment with efficacy claims in adult amblyopia!
Other amblyopia software programs are mostly used to treat children, when patching therapy may still be effective and are not indicated as a standalone therapy. They are indicated to use in combination with patching in children.
Additional amblyopia software programs are used to treat convergence insufficiency.

No, RevitalVision uses unique perceptual learning technology, scientifically and clinically proven with randomized controlled double-blind studies, published in pear reviewed medical journals. Unlike binocular training programs, RevitalVision is FDA approved for adult amblyopia as a standalone therapy.

By improving the brain's visual processing to perform better than normal, it compensates for some blurry image caused by the small refractive error.

RevitalVision has no effect on patient refraction nor on patient accommodation capabilities. It enables patients with small refractive error to see better without correction despite of the small refractive error.

More than 20 clinical studies tested the efficacy of RevitalVision in different clinical indications, by different clinicians and in different countries (USA, Europe and Asia), all showing similar clinical outcome. 7 studies have been published in pear reviewed medical journals, 3 of them are randomized controlled studies. Most of the studies are available on our website.

Possible explanation of the improvement mechanism is the lack of prolonged effective cortical stimulation, caused by a blurred or damaged image transferred from the retina to the brain, resulting in reduced cortical activity. Thus, in addition to the anatomical damage to the eye, there is secondary gradually-evolved damage to the quality of the image processing in the brain.
Similar to amblyopia, effective stimulation and perceptual learning process enables significant improvement in cortical activity, resulting in improved visual acuity and contrast sensitivity, despite the absence of any anatomical improvement or changes during the course of the disease.

85% of patients improve by 2 – 2.5 VA lines (in ETDRS/ LogMar) and 100% in contrast sensitivity (using FACT sine wave test), approximately 10% do not respond.

Yes, follow up of 1-2 years in clinical studies shows the improvement gained with RevitalVision remains. In fact, amblyopic patients demonstrate additional spontaneous improvement in CS and Stereo after 1 year from completing the program.
Just like learning to walk, riding a bicycle and learning to swim have a long-lasting effect, so does RevitalVision.

With the exception of Post Cataract and Sports Vision programs, all other programs require clinical examination and prescription.

Currently, the program is paid privately. However, the company had started a process of applying for a CPT code in the USA with the goal of achieving health insurance reimbursement for the amblyopia program.